Приказ основних података о документу

dc.creatorSpasojević, Ivan
dc.creatorMaksimović, Vuk
dc.creatorZakrzewska, Joanna
dc.creatorBačić, Goran
dc.date.accessioned2022-04-05T14:07:26Z
dc.date.available2022-04-05T14:07:26Z
dc.date.issued2005
dc.identifier.issn1549-9596
dc.identifier.urihttp://rimsi.imsi.bg.ac.rs/handle/123456789/140
dc.description.abstractIn the present study, we showed that the antineoplastic drug 5-fluorouracil (5-FU) induces in vitro exposure-time/dose-dependent changes on the level of an erythrocyte's morphology, ionic balance, and membrane fluidity. These changes are partially or fully irreversible, and we suggest that they are provoked by an irreversible depletion of ATP. Because of these changes that could also occur in vivo during 5-FU infusion, a certain amount of erythrocytes with echinocytic shape and diminished ability to deliver oxygen is present in blood for longer periods of time. This renders oxygen transport and delivery more difficult, leaving the heart with an insufficient supply of oxygen, thus leading to cardiotoxicity.en
dc.publisherAmer Chemical Soc, Washington
dc.rightsrestrictedAccess
dc.sourceJournal of Chemical Information and Modeling
dc.subject5-fluorouracil
dc.subjectcytostatic
dc.subjectcardiotoxicity
dc.subjectmembrane fluidity
dc.subjectEPR
dc.subjectspin label
dc.titleEffects of 5-fluorouracil on erythrocytes in relation to its cardiotoxicity: Membrane structure and functioningen
dc.typearticle
dc.rights.licenseARR
dc.citation.epage1685
dc.citation.issue6
dc.citation.other45(6): 1680-1685
dc.citation.rankaM21
dc.citation.spage1680
dc.citation.volume45
dc.identifier.doi10.1021/ci0501746
dc.identifier.pmid16309273
dc.identifier.scopus2-s2.0-28944432545
dc.identifier.wos000233689400031
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу